AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30914100 — intervention group
Group type: EXPERIMENTAL
Intervention: New modified sick clothes
Number of subjects: 408
Study 28900370 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine laboratory preoperative tests (POTs)
Number of subjects: 1129
Study 25844854 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-stability-training group (PS group)
Number of subjects: 46
Study 25844854 — intervention group
Group type: COMPARATOR
Intervention: Traditional endurance-training group (ET group)
Number of subjects: 46
Study 23703915 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic meniscectomy
Number of subjects: 102
Study 23703915 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment with strengthening exercises
Number of subjects: 102
Study 23703915 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study 23117648 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive exercises added to stretching and strengthening exercises and cryotherapy (Group 2)
Number of subjects: 0
Study 23117648 — intervention group
Group type: COMPARATOR
Intervention: Stretching and strengthening exercises and cryotherapy (Group 1, Control)
Number of subjects: 0
Study 23117648 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 0
Study 19411662 — intervention group
Group type: EXPERIMENTAL
Intervention: tolvaptan (vasopressin antagonist)
Number of subjects: 4133
Study 19411662 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 4133
Study 17716313 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD; 20 mg bid)
Number of subjects: 128
Study 17716313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 15222726 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (10 mg generic amlodipine)
Number of subjects: 0
Study 15222726 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (10 mg amlodipine)
Number of subjects: 0
Study 11486923 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked practice
Number of subjects: 0
Study 11486923 — intervention group
Group type: COMPARATOR
Intervention: Randomly interleaved practice
Number of subjects: 0
Study 9772954 — intervention group
Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 5461
Study 9772954 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 5461
Study 8153803 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard work tolerance program plus exercise on the B‐200 Isostation
Number of subjects: 0
Study 8153803 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard work tolerance program only
Number of subjects: 0
Study 8153803 — intervention group
Group type: COMPARATOR
Intervention: Control group (volunteers with neither back pain nor known underlying spinal pathology)
Number of subjects: 0
Study 2646004 — intervention group
Group type: EXPERIMENTAL
Intervention: CFPT (Cyclophosphamide, 5-Fluorouracil, Prednisone + Tamoxifen)
Number of subjects: 400
Study 2646004 — intervention group
Group type: COMPARATOR
Intervention: CFP (Cyclophosphamide, 5-Fluorouracil, Prednisone)
Number of subjects: 400
Study 1092398 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 8
Study 1092398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31897731 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated vertebral segmentation method using fine-tuned Mask R-CNN
Number of subjects: 428
Study 31034311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity Resistance Exercise Training (LIRET)
Number of subjects: 20
Study 31034311 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 20
Study 28125970 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal online coaching based on identified nutrition and lifestyle risk factors, with a maximum of three messages per week.
Number of subjects: 0
Study 28125970 — intervention group
Group type: COMPARATOR
Intervention: One recipe per week to maintain adherence to the program.
Number of subjects: 0
Study 25592201 — intervention group
Group type: EXPERIMENTAL
Intervention: Waste the Waist intervention (9 sessions)
Number of subjects: 108
Study 25592201 — intervention group
Group type: COMPARATOR
Intervention: Usual care and standardised information on cardiovascular risk and lifestyle (Controls)
Number of subjects: 108
Study 22865017 — intervention group
Group type: EXPERIMENTAL
Intervention: Three Component Model (3CM)
Number of subjects: 195
Study 22865017 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 195
Study 22315776 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive group (Group A)
Number of subjects: 60
Study 22315776 — intervention group
Group type: COMPARATOR
Intervention: Normotensive group (Group B)
Number of subjects: 60
Study 19919399 — intervention group
Group type: EXPERIMENTAL
Intervention: Resperate device-guided breathing exercises
Number of subjects: 30
Study 19919399 — intervention group
Group type: COMPARATOR
Intervention: Control group (listened to music)
Number of subjects: 30
Study 17545892 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid carbohydrate (CHO) (200 mL.h, 20% CHO (40 g.h, 160 kcal.h))
Number of subjects: 76
Study 17545892 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid CHO (200 mL.h, 20% CHO (40 g.h, 160 kcal.h)) every even hour and solid CHO (25 g of CHO, 10 g of protein, 2 g of fat, and 160 kcal.h) every odd hour
Number of subjects: 76
Study 17545892 — intervention group
Group type: EXPERIMENTAL
Intervention: Shift food items of approximately 150‐400 kcal at 90‐min intervals after breakfast
Number of subjects: 76
Study 17545892 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 76
Study 17545892 — intervention group
Group type: COMPARATOR
Intervention: Sack lunch
Number of subjects: 76
Study 15139984 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/HCV coinfection prevalence
Number of subjects: 1649
Study 15139984 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of HIV/HCV coinfection
Number of subjects: 1649
Study 15139984 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive values for HIV/HCV coinfection
Number of subjects: 1649
Study 15139984 — intervention group
Group type: COMPARATOR
Intervention: HIV disease progression
Number of subjects: 1649
Study 15139984 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of HIV/HCV coinfection among homosexual men
Number of subjects: 1649
Study 11488319 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated low-dose allergen exposure
Number of subjects: 0
Study 9791040 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral endopeptidase inhibitor (SCH 32615, 200 mg intravenously)
Number of subjects: 24
Study 9791040 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone (control group)
Number of subjects: 24
Study 7922474 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (letter-sound training)
Number of subjects: 22
Study 7922474 — intervention group
Group type: EXPERIMENTAL
Intervention: OR (onset-rhyme training)
Number of subjects: 22
Study 7922474 — intervention group
Group type: EXPERIMENTAL
Intervention: WW (whole word training)
Number of subjects: 22
Study 7922474 — intervention group
Group type: COMPARATOR
Intervention: Math-training control program
Number of subjects: 22
Study 7922474 — intervention group
Group type: EXPERIMENTAL
Intervention: All literacy-training groups
Number of subjects: 22
Study 7922474 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD-trained subjects
Number of subjects: 22
Study 3279774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus vancomycin
Number of subjects: 470
Study 3279774 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin plus vancomycin
Number of subjects: 470
Study 3279774 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin plus ceftazidime and vancomycin
Number of subjects: 470
Study 31984443 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec 200 U/ml (degludec U200)
Number of subjects: 1609
Study 31984443 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 300 U/ml (glargine U300)
Number of subjects: 1609
Study 31644511 — intervention group
Group type: EXPERIMENTAL
Intervention: UE videolaryngoscopy
Number of subjects: 440
Study 31644511 — intervention group
Group type: COMPARATOR
Intervention: Macintosh's direct laryngoscopy
Number of subjects: 440
Study 29949479 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-minute application of 38% hydrogen peroxide bleaching agent
Number of subjects: 44
Study 29949479 — intervention group
Group type: COMPARATOR
Intervention: Two 20-minute applications of 38% hydrogen peroxide bleaching agent
Number of subjects: 44
Study 27351245 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg/day)
Number of subjects: 100
Study 27351245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 24439637 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency TENS treatment
Number of subjects: 55
Study 24439637 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS treatment
Number of subjects: 55
Study 22585692 — intervention group
Group type: EXPERIMENTAL
Intervention: bortezomib-thalidomide-dexamethasone (VTD)
Number of subjects: 269
Study 22585692 — intervention group
Group type: COMPARATOR
Intervention: thalidomide-dexamethasone (TD)
Number of subjects: 269
Study 19712802 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (intramuscular injection every 6 weeks)
Number of subjects: 70
Study 19712802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 17961387 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 s freezing intercostal nerves with PCIA
Number of subjects: 150
Study 17961387 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 s freezing intercostal nerves
Number of subjects: 150
Study 17961387 — intervention group
Group type: COMPARATOR
Intervention: 60 s freezing intercostal nerves
Number of subjects: 150
Study 17961387 — intervention group
Group type: COMPARATOR
Intervention: PCIA
Number of subjects: 150
Study 15223252 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (i.v.IG)
Number of subjects: 19
Study 15223252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 11259862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg for two days)
Number of subjects: 12
Study 11259862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9482562 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of terfenadine and pseudoephedrine
Number of subjects: 41
Study 9482562 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine alone
Number of subjects: 41
Study 8046193 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (physician-targeted treatment recommendations)
Number of subjects: 175
Study 8046193 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 175
Study 8046193 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 175
Study 3242386 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg x 3)
Number of subjects: 30
Study 3242386 — intervention group
Group type: COMPARATOR
Intervention: Estramustine (280 mg x 2)
Number of subjects: 30
Study 31676298 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care according to health promotion model
Number of subjects: 80
Study 31676298 — intervention group
Group type: COMPARATOR
Intervention: Control group nursing care
Number of subjects: 80
Study 30681707 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 payment incentive
Number of subjects: 2275
Study 30681707 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 payment incentive
Number of subjects: 2275
Study 30681707 — intervention group
Group type: EXPERIMENTAL
Intervention: $20 payment incentive
Number of subjects: 2275
Study 30681707 — intervention group
Group type: COMPARATOR
Intervention: All payment groups
Number of subjects: 2275
Study 27918744 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg + Esomeprazole 20 mg (NE)
Number of subjects: 46
Study 27918744 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 500 mg
Number of subjects: 46
Study 26353772 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with S-1/irinotecan/bevacizumab (SIRB or IRIS/bevacizumab)
Number of subjects: 450
Study 23937005 — intervention group
Group type: EXPERIMENTAL
Intervention: Malleus removal group (A)
Number of subjects: 59
Study 23937005 — intervention group
Group type: EXPERIMENTAL
Intervention: Retaining only the malleus handle group (B)
Number of subjects: 59
Study 23937005 — intervention group
Group type: COMPARATOR
Intervention: Intact malleus group (C)
Number of subjects: 59
Study 21219394 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-cooled Nd:YAG laser (1064 nm, 6 W, 400 mJ) adjunctive to supra- and subgingival debridement (SRP)
Number of subjects: 19
Study 21219394 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 19
Study 21219394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Nd:YAG laser and SRP alone)
Number of subjects: 19
Study 19901211 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid intervention
Number of subjects: 106
Study 17434020 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sensitivity (LS) urine pregnancy tests
Number of subjects: 1080
Study 17434020 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity (HS) urine pregnancy tests
Number of subjects: 1080
Study 17434020 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonography (control)
Number of subjects: 1080
Study 15657568 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol sedation
Number of subjects: 34
Study 15657568 — intervention group
Group type: COMPARATOR
Intervention: Midazolam sedation
Number of subjects: 34
Study 11167223 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of refraction using Nidek ARK 900 autorefracto‐keratometer
Number of subjects: 1045
Study 11167223 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity tested on a Snellen chart
Number of subjects: 1045
Study 11167223 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of corneal astigmatism measured by keratometer
Number of subjects: 1045
Study 9063317 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G (single-dose)
Number of subjects: 19
Study 9063317 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 19
Study 8224684 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal endoscopic ultrasonography
Number of subjects: 20
Study 8224684 — intervention group
Group type: COMPARATOR
Intervention: Endoscopy
Number of subjects: 20
Study 2878680 — intervention group
Group type: EXPERIMENTAL
Intervention: xamoterol 200 mg
Number of subjects: 11
Study 2878680 — intervention group
Group type: COMPARATOR
Intervention: atenolol 50 mg
Number of subjects: 11
Study 31594394 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg press (LP) at 10 and 20 repetition maximum (RM)
Number of subjects: 10
Study 31594394 — intervention group
Group type: EXPERIMENTAL
Intervention: Bench press (BeP) at 10 and 20 repetition maximum (RM)
Number of subjects: 10
Study 29053185 — intervention group
Group type: EXPERIMENTAL
Intervention: High MLH1 expression levels
Number of subjects: 117
Study 29053185 — intervention group
Group type: EXPERIMENTAL
Intervention: Low MLH1 expression levels
Number of subjects: 117
Study 29053185 — intervention group
Group type: COMPARATOR
Intervention: Both arms combined
Number of subjects: 117
Study 27367832 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine plus CBT
Number of subjects: 142
Study 27367832 — intervention group
Group type: COMPARATOR
Intervention: placebo plus CBT
Number of subjects: 142
Study 24735588 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute geriatric ward (intervention group)
Number of subjects: 329
Study 24735588 — intervention group
Group type: COMPARATOR
Intervention: Orthopedic ward (control group)
Number of subjects: 329
Study 23998557 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (PLC) 2g/day orally for 4 months
Number of subjects: 239
Study 23998557 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (PLC)
Number of subjects: 239
Study 23998557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 20806094 — intervention group
Group type: COMPARATOR
Intervention: RelyX (RelyX Unicem; 3M ESPE)
Number of subjects: 44
Study 20806094 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step (One-Step + Duo-link; Bisco)
Number of subjects: 44
Study 20806094 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F (ED primer + Panavia F; Kuraray)
Number of subjects: 44
Study 20806094 — intervention group
Group type: EXPERIMENTAL
Intervention: Variolink II (Excite DSC + Variolink II; Ivoclar Vivadent)
Number of subjects: 44
Study 17692951 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI
Number of subjects: 128
Study 17692951 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI plus candesartan
Number of subjects: 128
Study 17692951 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ACEI or angiotensin receptor blocker)
Number of subjects: 128
Study 16815780 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal exercise task
Number of subjects: 24
Study 16815780 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal exercise task
Number of subjects: 24
Study 16815780 — intervention group
Group type: COMPARATOR
Intervention: Resting control
Number of subjects: 24
Study 16815780 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise tasks (maximal and submaximal)
Number of subjects: 24
Study 12514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF)
Number of subjects: 61041
Study 12514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF) only at baseline
Number of subjects: 61041
Study 12514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF) only after baseline
Number of subjects: 61041
Study 12514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF) at baseline and later
Number of subjects: 61041
Study 12514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of mild-to-moderate heart failure (HF)
Number of subjects: 61041
Study 11594525 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ autoPBSCT with total body irradiation (TBI) of 1200 cGy
Number of subjects: 18
Study 11594525 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ autoPBSCT with non-TBI regimen
Number of subjects: 18
Study 11594525 — intervention group
Group type: COMPARATOR
Intervention: Unselected autoPBSCT with non-TBI regimen
Number of subjects: 18
Study 11594525 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ autoPBSCT with TBI
Number of subjects: 18
Study 9196934 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dorzolamide hydrochloride (3 times a day and 5 times a day)
Number of subjects: 5
Study 9196934 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetazolamide (2 weeks)
Number of subjects: 5
Study 9196934 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 weeks)
Number of subjects: 5
Study 8466377 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (18 months duration, 14 weekly group meetings followed by monthly maintenance sessions)
Number of subjects: 564
Study 8466377 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 564
Study 8466377 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control condition
Number of subjects: 564
Study 3803130 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded esophageal balloon distention (10 cc total volume, inflated with 1-cc increments)
Number of subjects: 80
Study 3803130 — intervention group
Group type: COMPARATOR
Intervention: Intraesophageal acid perfusion and intravenous edrophonium (80 micrograms/kg)
Number of subjects: 80
Study 29436329 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based cognitive-behavioural therapy (iCBT) with protocol-driven therapist feedback
Number of subjects: 240
Study 29436329 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based cognitive-behavioural therapy (iCBT) with feedback on demand
Number of subjects: 240
Study 29436329 — intervention group
Group type: COMPARATOR
Intervention: waiting list
Number of subjects: 240
Study 27999808 — intervention group
Group type: EXPERIMENTAL
Intervention: New algorithm for measuring compression depth and rate using two accelerometers
Number of subjects: 1
Study 27999808 — intervention group
Group type: COMPARATOR
Intervention: Foam mattress with backboard
Number of subjects: 1
Study 27999808 — intervention group
Group type: COMPARATOR
Intervention: Sprung mattress with backboard
Number of subjects: 1
Study 24980650 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 41
Study 24980650 — intervention group
Group type: COMPARATOR
Intervention: Walking Control
Number of subjects: 41
Study 22486595 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week online ACT intervention
Number of subjects: 503
Study 22486595 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 503
Study 22486595 — intervention group
Group type: EXPERIMENTAL
Intervention: Believability of Anxious Feelings and Thoughts Questionnaire (BAFT)
Number of subjects: 503
Study 20533013 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop system for propofol administration
Number of subjects: 40
Study 20533013 — intervention group
Group type: COMPARATOR
Intervention: Manual administration of propofol (Control)
Number of subjects: 40
Study 18606952 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 13321
Study 18606952 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 13321
Study 18606952 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 13321
Study 18606952 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-suppressing agents
Number of subjects: 13321
Study 18606952 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs
Number of subjects: 13321